Global Health Ltd Share Price Today

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 25% at ₹0.5/Share	14-Aug-2026	14-Aug-2026
DividendsFinal Dividend of 25% at ₹0.5/Share	22-Aug-2025	22-Aug-2025

Mutual Fund Holder	Jul 26 Shares held	Aug 26 Shares held
Invesco India Midcap Fund - Regular Plan - Growth	45.77 Lac	45.77 Lac no change
UTI Flexi Cap Fund - Regular Plan - IDCW	33.63 Lac	33.69 Lac (0.2%)
Invesco India Smallcap Fund - Regular Plan - Growth	21.94 Lac	21.94 Lac no change
Invesco India Contra Fund - Regular Plan - Growth	21.02 Lac	21.02 Lac no change
Invesco India Large & Mid Cap Fund - Regular Plan - Growth	17.04 Lac	17.04 Lac no change

AALGO BREATHS I SEBI RA

5 Sep • 2:42 PM · SEBI-Registered Analyst

GLOBAL HEALTH LTD – TECHNICAL ANALYSIS With Discussion

MEDANTA

Global Health Ltd is currently showing an interesting technical setup on the daily chart. The stock has witnessed a strong upward movement from lower levels and is now consolidating around the ₹1,470 zone. The overall price structure remains positive, but the recent candles indicate some volatility and profit booking near the higher levels. Traders should closely monitor the immediate support and resistance zones for the next directional move. The chart suggests that the ₹1,420–₹1,380 zone may act as an important support area. As long as the stock manages to sustain above this zone, the broader bullish structure may remain intact. On the upside, ₹1,500–₹1,540 appears to be an important resistance zone. A sustained breakout above this level could strengthen bullish momentum and may open the door for further upside. The moving averages and price structure indicate that the stock is currently in a consolidation phase after a strong rally. Volume and price action should be monitored closely for confirmation of the next trend. A breakout with strong volume may attract fresh buying interest, while a breakdown below the key support zone could increase selling pressure. Key Levels to Watch: 📈 Resistance: ₹1,500 | ₹1,540 | ₹1,585 📉 Support: ₹1,420 | ₹1,380 | ₹1,339 ⚠️ Disclaimer: This technical analysis is for educational and informational purposes only and should not be considered as investment advice. Please use proper risk management and consult a qualified financial advisor before making any trading or investment decision.

AALGO BREATHS I SEBI RA

26 Aug • 8:22 PM · SEBI-Registered Analyst

Global Health Ltd. – Bullish Setup Discussion

MEDANTA

The stock is currently consolidating near a key support zone, with fresh buying interest emerging after a strong bullish candle. Price action indicates that the support area around ₹1402–₹1438 is holding well, while short-term bullish momentum is gradually improving. The broader rising channel structure remains intact, keeping the overall technical setup positive as long as the important support levels are defended. 🔎 Technical View: • Strong support holding around ₹1402–₹1438 • Fresh buying interest visible near support • Bullish momentum showing signs of improvement • Rising channel structure remains intact • ₹1473 is the key breakout level to watch • Sustained price action above resistance may strengthen the bullish setup 🔑 Key Levels: 🟢 Support: ₹1438 / ₹1402 🟢 Major Support: ₹1367–₹1345 🔴 Resistance: ₹1473 / ₹1509 🚀 Potential Upside Levels: 🎯 ₹1473 🎯 ₹1509 🎯 ₹1545 🎯 ₹1580+ 📈 Trading View: A sustained move above ₹1473 could trigger fresh bullish momentum and potentially open the way towards ₹1509, ₹1545 and ₹1580+ levels. On the downside, ₹1402 remains an important risk level. A decisive breakdown below ₹1402 could weaken the current setup and increase the possibility of a move towards ₹1367–₹1345. Traders should closely monitor price action, volume and overall market conditions around these key levels, as volatility can impact the movement significantly. ⚠️ For educational purposes only. Not a buy/sell recommendation. Please conduct your own research and consult a SEBI-registered investment professional before making any investment decision. — AALGO BREATHS 📊

Dhwani Patel

23 Aug • 2:20 PM · SEBI-Registered Analyst

Medanta Breaks Major Resistance, Eyes New Highs

MEDANTA

Global Health, operating under the Medanta brand, continues to strengthen its fundamental profile through strong patient volumes, capacity expansion and improving contribution from newer hospitals. Q1 FY27 consolidated total income rose 26.2% YoY to ₹1,326 crore, while EBITDA increased 23.5% to ₹315 crore. Patient volumes remained robust, with IP volumes growing 28% and OP volumes rising 34% YoY, highlighting healthy demand across the network. The Noida facility is also moving closer to profitability, reducing the drag from newer capacity. Management is simultaneously pursuing a large expansion pipeline, including the revised Guwahati project that will increase planned capacity to 650 beds. Technically, Medanta has delivered a significant breakout from a multi-year descending resistance structure visible on the daily chart. The stock had been consolidating within a broad contracting formation since the 2024 peak, with resistance gradually declining from the ₹1,550–₹1,600 region while the lower boundary established support near ₹950–₹1,000. The recent rally has taken the price through the upper trendline and the previous resistance around ₹1,400, with the stock now trading close to its lifetime-high zone. This breakout is important because it marks a transition from a prolonged consolidation phase into potential price discovery. Sustained trading above ₹1,400–₹1,420 would keep the breakout intact, while a decisive move above the recent high near ₹1,450 can reinforce the bullish structure and open the possibility of fresh all-time highs. On the downside, ₹1,350–₹1,400 becomes the first important support zone, followed by ₹1,250–₹1,300. As long as the breakout zone holds on closing basis, the technical bias remains firmly bullish.

Pankaj pawar

25 Jun • 11:19 AM · SEBI-Registered Analyst

PINELABS

══════════════════════════════════════════════ 📊 BULK DEALS | BLOCK DEALS | INSIDER TRADING 📅 Date: 24 June 2026 ══════════════════════════════════════════════ BUYING INTEREST ▶ Credent Global Finance • DP Global Wealth Management bought 10,02,060 shares @ ₹29.68 ▶ LESL (SME) • Colourshine Hosiery Pvt Ltd – 17,82,000 shares • Deep Health AI India Ltd – 90,30,000 shares • Hemang Navinbhai Haria HUF – 8,04,000 shares • India Fast Forward Advisory – 11,10,000 shares • Raxitkumar Patel – 8,58,000 shares ▶ Mahalaxmi Rubtech • Neo Apex Venture LLP – 90,106 shares @ ₹130.20 • Sway Financial Services – 55,243 shares @ ₹136.60 ▶ Pine Labs • Axis Mutual Fund bought 96,15,267 shares @ ₹154 ▶ SBC Exports • Deepika Gupta bought 25,00,000 shares @ ₹41.74 ══════════════════════════════════════════════ 🔴 SELLING INTEREST ▶ AFCOM (SME) • Thiagaraj A sold 3,00,000 shares @ ₹116.40 ▶ Credent Global Finance • Dilip Nanji Chheda sold 7,11,897 shares ▶ Delhivery • Alpha Wave Ventures LP sold 1,44,44,800 shares @ ₹460 ▶ LESL (SME) • Anant Securities sold 9,96,000 shares ▶ Mahalaxmi Rubtech • Nishant Pitti sold 4,03,611 shares ▶ Markolines Pavement • Hi Klass Trading & Investment sold 3,94,555 shares ▶ Narmada Agrobase • Chanakya Opportunities Fund – 4,53,704 shares • L7 Hitech Pvt Ltd – 1,50,000 shares • Metasoni Alloys Pvt Ltd – 2,00,000 shares • Sillenium Infra Project Pvt Ltd – 4,00,000 shares ▶ Pine Labs • Actis Pine Labs Investment Holding sold 2,39,09,033 shares ▶ Ratnaveer Precision • Chungath Karunakaran Padmanabhan sold 4,41,000 shares ▶ SBC Exports • Nitin Kapoor sold 24,00,000 shares ▶ Shadowfax Technologies • Mirae Asset Late Stage Opportunities sold 56,50,000 shares ▶ Uravi Defence • Viney Corporation Ltd sold 4,22,107 shares 📌 Key Highlights • Largest Buy: Axis Mutual Fund – Pine Labs • Largest Sell: Actis – Pine Labs (2.39 Cr Shares) • Heavy Activity Seen: LESL (SME), Pine Labs, Delhivery, Narmada Agrobase

DEEPAK PAL

21 Jun • 5:48 AM · SEBI-Registered Analyst

Beds कम, मरीज ज्यादा! Healthcare Sector में बन रहा है Multi-Year Growth Opportunity

भारत में Healthcare Demand लगातार बढ़ रही है, लेकिन Hospital Beds की उपलब्धता अभी भी जरूरत से काफी कम है। कई रिपोर्ट्स के अनुसार देश में लगभग 20 लाख अतिरिक्त Hospital Beds की आवश्यकता है, जबकि Bed-to-Population Ratio अभी भी वैश्विक मानकों से काफी नीचे है। इस वजह से आने वाले वर्षों में मौजूदा Hospital Chains के लिए मजबूत Growth Runway दिखाई दे रहा है। Growth Story क्यों मजबूत है? बढ़ती Health Insurance Coverage Aging Population और Chronic Diseases में वृद्धि Medical Tourism का विस्तार Tier-2 और Tier-3 शहरों में Healthcare Infrastructure की कमी Hospital Beds की Structural Shortage इसी Demand-Supply Gap को पूरा करने के लिए निजी अस्पताल अगले कुछ वर्षों में हजारों नए Beds जोड़ने की योजना बना रहे हैं। फिर भी उद्योग विशेषज्ञों का मानना है कि मांग की तुलना में क्षमता अभी भी कम रहेगी। किन शेयरों पर रहेगी सबसे ज्यादा नजर?

APOLLOHOSP

MAXHEALTH

FORTIS

MEDANTA

ASTERDM

YATHARTH

इन कंपनियों के पास पहले से मजबूत ब्रांड, उच्च Occupancy और विस्तार योजनाएं हैं, जिससे वे बढ़ती मांग का लाभ उठा सकती हैं. क्या कहती हैं रिपोर्ट्स? -----> Private Hospital Chains FY2030 तक 34,000+ नए Beds जोड़ने की तैयारी में हैं। *Market View:: जब मांग लगातार बढ़ रही हो और सप्लाई अभी भी कम हो, तब मौजूदा मजबूत खिलाड़ियों के लिए Growth का रास्ता अक्सर लंबा होता है।*

Sarathi Research

9 Jun • 3:50 PM · SEBI-Registered Analyst

Panacea Biotec Soars to Record High on Dengue Vaccine Breakthrough!

Shares of

PANACEABIO

surged as much as 17% intraday, extending gains for the sixth consecutive session and hitting a fresh all-time high of ₹647. The rally followed the company's announcement of the DENSTAR Project, a major initiative aimed at advancing the licensure of its dengue vaccine, DengiAll, across sub-Saharan Africa and supporting wider global adoption. The four-year program is funded under the Global Health European & Developing Countries Clinical Trials Partnership 3 Joint Undertaking, backed by the European Union. The development strengthens Panacea Biotec's global healthcare ambitions and has boosted investor optimism around its vaccine portfolio. Disclaimer: Investments in securities are subject to market risk. This is for educational purposes only. Investors must verify information before investing and consider their financial position & risk profile.

Global Health Ltd. Share Price

Overview

Market Data

Open Price

Prev. Close

Day Low

Day High

52 Week Low

52 Week High

Fundamentals

Quick Bite

Price To Earnings Ratio

Sector PE

PB Ratio

Sector PB

EPS

Dividend Yield

Today's Volume

5 Day Avg. Volume

PEG Ratio

Market Cap.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Mutual Fund Ownership

About Global Health Ltd. 👋

Expert Opinions

Frequently Asked Questions

What is the share price of Global Health Ltd.?

What is the market cap of Global Health Ltd.?

Should I buy Global Health Ltd. stock now?

What is the 52 week high and low of Global Health Ltd.?

Is the Global Health Ltd. stock good to buy?

Is Global Health Ltd. a good buy for the long term?

Is Global Health Ltd. overvalued or undervalued?

What is the PE and PB ratio of Global Health Ltd.?